Review of the pharmaceutical industry Series 8- 2008 new opportunities and new marketing new medical reform.docVIP

 PAGE \* MERGEFORMAT 5 ‘Review of the pharmaceutical industry’ Series 8: 2008 new opportunities and new marketing new medical reform 30 years of reform and opening up, China’s economic growth in the brink of collapse as the world’s four largest economic entities. This is the burst of vitality from the malaise to 30 years, is the development of major sub-sectors growing relaxation of 30 years. In the reform and opening up the first 30 years, the pharmaceutical industry with a warming of the atmosphere, in the midst of looking into the eyes of the Dayun year 2008, poised and hair: First, the ‘new medical reform’ will become the market’s most dynamic engine of rapid growth. March 5, Premier Wen Jiabao made the ‘government work report’ clearly states that the State Council organized medical and health system resources to the study to deepen the problem, has developed a preliminary program, we should firmly push forward this reform so that everyone can enjoy basic medical and health services, and clear medical and health undertakings in 2008 the four major events. According to reports, the new medical reform program ‘with a high gold content’, ‘government finances at least a thousand billion to increase the input’. The injection of capital will eventually flow to medical services and drugs consumption, and promote the rapid growth of the pharmaceutical market; the same time, new medical reform program referred to in the improvement of health-care system will also further rationalize the system of the entire pharmaceutical industry, various links of the chain. The new medical reform program set the tone, the pharmaceutical companies the opportunities abound. Second, the pharmaceutical industry policy environment will gradually be ‘moderate’. It has been predicted that this year’s pharmaceutical industry will face a relatively stable policy environment conducive to promoting the progress of higher pharmaceutical industry. ‘Antitrust’ and the New Deal will also be t